This issue covers the period 6-12 October 2019 and includes updates on Ebola virus disease, extensively drug-resistant Klebsiella pneumoniae, West Nile virus, mass gathering monitoring (Japan, Rugby World Cup 2019), Poliomyelitis, Measles, Zika virus disease, seasonal influenza, XDR-Typhoid fever.
In 2017, 8.3% (11 787) of the patients who stayed in intensive-care units (ICUs) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection, or urinary tract infection).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 September-5 October 2019 and includes updates on Ebola virus disease, extensively drug-resistant Klebsiella pneumoniae, mass gathering monitoring (Japan, Rugby World Cup 2019), Middle East respiratory syndrome coronavirus, Plasmodium cynomolgi infection, poliomyelitis, West Nile virus, and yellow fever.
Carbapenem resistance in Enterobacteriaceae such as Klebsiella pneumoniae and Escherichia coli poses a significant threat to patients and healthcare systems in all European Union/European Economic Area (EU/EEA) countries. Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality, primarily due to delays in administration of effective treatment and the limited availability of treatment options.
ECDC is organising a short course on “Control of multidrug-resistant micro-organisms (MDROs) in health care settings”. This training opportunity is addressed at healthcare professionals from European Union (EU) and European Economic Area (EEA) countries with current or future responsibility for the prevention and control of healthcare-associated infections (HAIs) due to MDROs working at national or local level. The course is offered by invitation only and participants are identified through the ECDC Coordinating Competent Bodies.